Skip to main content

Table 1 The clinical and pathologic characteristics of the included patients

From: CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)

Variable Patients (178) CDCA5 overexpression group Low CDCA5 expression group Odds Ratio P value
Liver cirrhosis, n(%) 128 (71.91) 63 (70.79) 65 (73.03) 0.895 0.739
Tumor diameter, median (range) 5.88 ± 3.83 6.67 ± 3.97 5.11 ± 2.42 0.890 0.006
Tumor number, (%)     0.624 0.189
 1 156 (87.64) 82(92.13) 74 (83.15)   
 2 16 (8.99) 5 (5.62) 11 (12.36)   
  ≥ 3 6 (3.37) 2(2.25) 4 (4.49)   
Tumor margin,< 2/≥2 cm 45/178 22/67 23/66 0.942 0.897
Anatomic/nonanatomic liver resection 73/105 38/51 35/54 1.105 0.648
Intraoperative blood transfusion, Yes/No 27/151 15 / 74 12 / 77 1.301 0.531
Tumor capsule, complete/incomplete 88/90 39 / 50 43 / 46 0.834 0.548
Microvascular invasion, present/absent 44 / 134 28 / 61 16 / 73 2.094 0.037
Edmondson-Steiner Grade I / II / III / IV 33 / 78 / 65 /2 12 / 37 / 38 / 2 21 / 41 / 27 / 0 0.608 0.089